Imagine a simple shot, one already familiar to millions for preventing a painful skin condition, holding the power to shield the mind from a devastating disease like dementia—a condition impacting over 55 million people worldwide with no cure in sight. That’s the startling promise emerging from a
Imagine a woman in her late 60s, recently retired, enjoying her newfound freedom, only to face a devastating diagnosis of breast cancer. What if something as seemingly controllable as her weight could have dramatically altered her risk? This scenario is becoming all too common, as research reveals
Imagine a world where life-altering therapies for genetic disorders, cancer, and infectious diseases are not just a distant dream but a tangible reality, delivered precisely to the cells that need them most. RNA therapeutics hold this transformative promise, yet their potential remains locked
Ivan Kairatov has spent years at the crossroads of oncology and drug development, translating trial signals into day-to-day decisions for patients with localized prostate cancer. In this conversation, he unpacks new evidence showing that most of the value from androgen deprivation therapy (ADT)
Imagine a world where a diagnosis of gastric cancer no longer carries the weight of a dire prognosis, where innovative treatments offer a real chance at long-term survival even for those in the early stages of this aggressive disease. This vision is inching closer to reality with the recent
A therapy that should unleash the immune system instead fuels a tumor’s growth, and the only way to see why is to listen to each cell speak for itself; that is the everyday paradox that single-cell RNA sequencing (scRNA-seq) now makes decipherable in real time. In oncology, this shift from average
